This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Hypervitaminosis D
E4_HYPER_VIT_D
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
12 |
4. Check minimum number of eventsNone |
12 |
5. Include endpointsNone |
12 |
6. Filter based on genotype QC (FinnGen only) |
12 |
Control definitions (FinnGen only)
- Control exclude
- E4_OBESITY_HYPER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E67
- Name in latin
- Hypervitaminosis D
Similar endpoints
↥List of similar endpoints to
Hypervitaminosis D
based on the number of shared cases.
Similar with more cases:
- Other hyperalimentation
- Obesity and other hyperalimentation
- Other nutritional deficiencies
- Endocrine, nutritional and metabolic diseases
- Factors influencing health status and contact with health services
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 77 | 52 | 24 |
| Only index persons | 61 | 47 | 14 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 59.51 | 64.50 | 47.84 |
| Only index persons | 61.22 | 64.98 | 48.60 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 12 | 10 | - |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | - |
| Median age at first event (years) | 60.49 | 59.20 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3012095) Magnesium [Moles/volume] in Serum or Plasma
5
19
3.75
1.37
4.2
1.9
mmol/l
0.8
0.8
—
5
19
(3013512) EKG study
6
30
2.97
1.06
2.8
3.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
6
32
2.73
0.99
3.5
2.5
—
—
—
0
0
(3044889) 12 lead EKG panel
5
77
0.40
0.68
6.4
3.8
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
12
98
+∞
0.67
19.8
15.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
5
30
2.13
0.52
5.8
4.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
6
42
1.85
0.45
16.0
13.2
e9/l
0.0
0.0
—
6
37
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
15
0.00
0.45
0.0
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
12
106
+∞
0.44
9.6
11.7
u/l
22.5
25.3
0.53
12
101
(3023103) Potassium [Moles/volume] in Serum or Plasma
12
103
+∞
0.44
24.4
16.2
mmol/l
3.9
4.0
0.75
12
97
(3020564) Creatinine [Moles/volume] in Serum or Plasma
12
103
+∞
0.44
22.2
18.4
umol/l
99.5
70.6
0.99
12
103
(3019550) Sodium [Moles/volume] in Serum or Plasma
12
103
+∞
0.44
23.8
16.4
mmol/l
139.9
139.7
0.10
12
97
(3000494) Fungus identified in Specimen by Culture
0
17
0.00
0.44
0.0
1.2
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
1.3
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
12
108
+∞
0.22
26.8
24.1
g/l
129.8
134.6
0.42
12
108
(3024731) MCV [Entitic volume]
12
108
+∞
0.22
26.7
23.8
fl
91.6
91.2
0.13
12
108
(3035941) MCH [Entitic mass]
12
108
+∞
0.22
26.7
23.8
pg
30.4
30.3
0.09
12
108
(3042936) Bacteria identified in Isolate by Culture
0
13
0.00
0.22
0.0
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
5
41
1.37
0.12
4.6
3.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
6
60
1.00
0.00
3.0
4.5
mmol/l
5.5
6.3
—
6
55
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
9.3
—
0
5
(3000492) Spirometry study
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.0
—
1.0
—
0
8
(3019060) Gas panel - Arterial blood
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
356.8
—
0
6
(3008898) HLA-B27 [Presence]
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
6
58
1.07
0.00
11.3
12.6
e9/l
3.9
4.6
—
6
52
(4035726)
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4010399)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
9.0
—
0
6
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
5
0.00
0.00
0.0
1.0
—
0.7
—
0
5
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
0
5
0.00
0.00
0.0
3.4
—
22.5
—
0
5
(40768443) Skin Pathology biopsy report
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
532.2
—
0
6
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
5
48
1.07
0.00
3.8
3.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
22.3
—
0
6
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_HYPER_VIT_D and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have E4_HYPER_VIT_D.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: E4_HYPER_VIT_D – Hypervitaminosis D
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data